Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock

J Invasive Cardiol. 2014 May;26(5):E50-1.

Abstract

Cardiogenic shock (CS) during elective percutaneous coronary intervention (PCI) is a rare but potentially lethal clinical condition. Pharmacological inotropic support and mechanical circulatory assistance with intra-aortic balloon pump (IABP) counterpulsation remains the gold-standard treatment. We report the case of a patient who developed refractory CS during elective PCI and was successfully managed with concomitant use of IABP and the Impella 2.5 L support device.

Publication types

  • Case Reports

MeSH terms

  • Cardiotonic Agents
  • Combined Modality Therapy
  • Coronary Artery Disease / therapy
  • Female
  • Heart-Assist Devices*
  • Hemodynamics / physiology*
  • Hemofiltration
  • Humans
  • Intra-Aortic Balloon Pumping*
  • Middle Aged
  • Percutaneous Coronary Intervention / adverse effects
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / physiopathology
  • Shock, Cardiogenic / therapy*
  • Treatment Outcome

Substances

  • Cardiotonic Agents